Topical metronidazole vs oral (oxy)tetracycline
Assessment of erythema or telangiectasia · Participants with rosacea
1 finding from 1 review
- no estimate extracted4 studies · 258 participantsLow
Findings
What do systematic reviews say?
28 questions · 28 findings · 4 reviews · Headline outcomes only
No studies found 7 · 25%GRADE not reported 3 · 10.7%Very low 4 · 14.3%Low 10 · 35.7%Moderate 4 · 14.3%High 0 · 0%
Topical metronidazole vs oral (oxy)tetracycline
Lesion count · Participants with rosacea
1 finding from 1 review
- no estimate extracted4 studies · 258 participantsModerate
Topical metronidazole vs oral (oxy)tetracycline
Time needed until improvement ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Topical metronidazole vs oral (oxy)tetracycline
Duration of remission ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Macrolides vs tetracycline
All‐cause mortality · patients with chronic obstructive pulmonary disease
1 finding from 1 review
- Head‐to‐head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease 2019 · Cochrane Headline outcomes onlyno estimate extracted1 study · 50 participantsGRADE not reported
Macrolides vs tetracycline
Quality of life Drug resistance/microbial sensitivity Serious adverse events Lung function Hospitalisations Adverse events/side effects Number of participants colonised with P aeruginosa · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
- Head‐to‐head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease 2019 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Quinolone vs tetracycline
All‐cause mortality · patients with chronic obstructive pulmonary disease
1 finding from 1 review
- Head‐to‐head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease 2019 · Cochrane Headline outcomes onlyno estimate extracted1 study · 50 participantsGRADE not reported
Quinolone vs tetracycline
Quality of life Drug resistance/microbial sensitivity Serious adverse events Lung function Hospitalisations Adverse events/side effects Number of participants colonised with P aeruginosa · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
- Head‐to‐head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease 2019 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found